No Data
No Data
Ocular Therapeutix Insiders Sell US$577k Of Stock, Possibly Signalling Caution
Quite a few Ocular Therapeutix, Inc. (NASDAQ:OCUL) insiders sold their shares over the past year, which may be a cause for concern. When evaluating insider transactions, knowing whether insiders are
Ocular Therapeutix Price Target Maintained With a $15.00/Share by Piper Sandler
Ocular Therapeutix Price Target Maintained With a $15.00/Share by Piper Sandler
Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $15
Piper Sandler analyst Biren Amin maintains $Ocular Therapeutix(OCUL.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 40.7% an
Ocular Therapeutix Jumps as TD Cowen Upgrades to Buy and Hikes PT
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Thursday.Shares of KB Home (NYSE:KBH) rose during Thursday's session as the company posted better-than-expected earnings a